Glaucoma Implants Market : Global Market Estimation, Dynamics, Trends, Competitor Analysis 2015-2020 and Forecast 2021-2027

$ PRICE - $ 3,000.00$ 8,900.00

Glaucoma Implants Market: By Disease Indication (Closed Angle Glaucoma (CAG), Open Angle Glaucoma (OAG), Secondary Glaucoma, Congenital Glaucoma and Other)By Type (Non-Valved Glaucoma Drainage implants, Valved Glaucoma Drainage implants), (End User (Eye Hospitals, Ophthalmology Clinics, and Outpatient Surgical Centers) By Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

The global glaucoma implants market size valued USD 562.6 million in 2020 and expected to reach USD 4,204.8 million by 2027, at a CAGR of 27.2% during the forecast period 2021-2027. Notwithstanding customary and laser medical procedure, there are an assortment of medications to bring down intraocular weight (IOP). On the off chance that these strategies alone come up short, specialists may propose inserts. Otherwise called “aqueous shunts” or “glaucoma drainage devices,” we’ll allude to them essentially as “implants”. The expanding number of instances of glaucoma is the crucial component that is probably going to empower the development of the worldwide glaucoma implants market in the following couple of years. The simple accessibility of restorative protection scope for treatment and analysis is evaluated to make lucrative open doors for the conspicuous players working in the worldwide glaucoma implants market in the coming years. Moreover, the expanding geriatric populace and the rising medicinal services consumption are anticipated to fuel the development of the glaucoma implants market. On the other hand, stringent government controls concerning marketing and approvals are anticipated to limit the development of the market.

Glaucoma Implants Market

MARKET SUMMARY
-
27.2% CAGR
  • Study Period– 2021 – 2027
  • Base Year– 2020
  • CAGR– 27.2%
  • Largest Market– Asia-Pacific
  • Fastest Growing Market– North-America

Glaucoma Implants Market

  • The global glaucoma implants market report gives comprehensive outlook across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa.
  • The report on global glaucoma implants market gives historical, current, and future market sizes (US$ Mn) on the basis of disease condition, type, end user and geographical regions.
Key Players
  • Novartis AG
  • Carl Zeiss Meditech AG
  • bbott Laboratories
  • Essilor International S.A
  • Allergan Inc.
Glaucoma Implants Market

Drivers And Restraints

Worldwide glaucoma implants market is exceedingly divided with a few nearby and global players offering diverse implantable items in the commercial center. Players or specialist organizations in the glaucoma implants market are concocting altered arrangement that tends to the patient prerequisites. Players in glaucoma implants market are creating fresher outlines which are impacted by viscoelastic innovation and others to increase bigger market income share in the visual inserts showcase. Glaucoma is one of the main sources of visual impairment all around. As indicated by information distributed by the Glaucoma Research Foundation, in 2016, around 3.0 million individuals in America were experiencing Glaucoma. With expanding frequency of glaucoma, the interest for glaucoma implants is relied upon to increment, accordingly, powering the market development.


North-America got significant share

Glaucoma Implants Market

Geographically Glaucoma Implants Market is segmented as Latin America, North America, Asia- Pacific, The Middle East & Africa and Europe. North America is a standout amongst the most lucrative region for glaucoma implants because of developing maturing populace and simple accessibility of repayment offices, which help the territorial market. The U.S. is most commanding nation in this locale, attributable to a substantial populace having strong protection scope, innovative headways, and maturing populace. Europe is relied upon to witness vigorous development inferable from expanded number of eye medical procedures, nearness of key players in the region. Also, enter players in the glaucoma implants are significantly concentrating on both created and creating districts markets to tap the expanded market interest for glaucoma implants. The Asia Pacific is foreseen to enlist positive development attributable to ideal patient socioeconomics and creating medicinal services foundation in the glaucoma implants area.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East
Glaucoma Implants Market Segmentation


Location

GEOGRAPHY


Report

Company Profile

  • Novartis AG (Switzerland)
  • Carl Zeiss Meditech AG (Germany)
  • bbott Laboratories (U.S.)
  • Essilor International S.A. (France)
  • Allergan, Inc. (U.S.)
  • Opcon Corporation (Japan)
  • NIDEK Co., Ltd. (Japan)
  • Bausch & Lomb, Inc. (U.S.)
  • STAAR Surgical Company (U.S.)

Description

The global glaucoma implants market size valued USD 562.6 million in 2020 and expected to reach USD 4,204.8 million by 2027, at a CAGR of 27.2% during the forecast period 2021-2027. Notwithstanding customary and laser medical procedure, there are an assortment of medications to bring down intraocular weight (IOP). On the off chance that these strategies alone come up short, specialists may propose inserts. Otherwise called “aqueous shunts” or “glaucoma drainage devices,” we’ll allude to them essentially as “implants”. The expanding number of instances of glaucoma is the crucial component that is probably going to empower the development of the worldwide glaucoma implants market in the following couple of years. The simple accessibility of restorative protection scope for treatment and analysis is evaluated to make lucrative open doors for the conspicuous players working in the worldwide glaucoma implants market in the coming years. Moreover, the expanding geriatric populace and the rising medicinal services consumption are anticipated to fuel the development of the glaucoma implants market. On the other hand, stringent government controls concerning marketing and approvals are anticipated to limit the development of the market.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX